Daniel G. Brown

New York
  • 885 Third Avenue
  • New York, NY 10022-4834
  • USA
 
 

Daniel Brown, a member of Latham's Intellectual Property Litigation Practice, is a seasoned patent litigator with extensive experience in the life sciences, and cross-disciplinary experience in areas including FDA and regulatory, antitrust and competition, Inter Partes Reexamination proceedings, trade secrets, business and licensing transactions, due diligence, and investigations.

  • Pharmaceutical and life sciences litigation
  • Cases arising under the Hatch-Waxman Act
  • Complex litigation involving simultaneous patent, antitrust, and FDA litigation
  • Patent litigation parallel with Patent Office reissue, reexamination, and interference proceedings
  • Coordination of litigation proceedings in multiple countries
  • FDA strategy and counseling, including filing or responding to citizen petitions, coordinating FDA strategy with litigation strategy
Recognition Highlights

  • Recognized for Healthcare - Life Sciences. The Legal 500 US 2017-2018
  • Recommended for Patent Litigation: Full Coverage. The Legal 500 US 2018
  • Selected as a 2015 IP Star by Managing IP magazine
  • Recognized as one of “‘the best patent lawyers in the Hatch-Waxman industry.’” The Legal 500 US 2015

In more than 25 years of experience, Mr. Brown has litigated successfully more than 40 Hatch-Waxman patent cases that resulted in either favorable judgments or settlements.

Mr. Brown’s litigations have involved many prominent pharmaceutical products, such as:

  • Bendeka ®
  • Ofirmev ®
  • Nascobal ®
  • Adrenalin ®
  • Treanda ®
  • Suboxone ®
  • Exelon Patch ®
  • Travatan ®, Travatan Z ®    
  • Ultram ER ®    
  • Keppra XR ®    
  • Focalin XR®    
  • Eloxatin ®    
  • Starlix ®    
  • Ultracet ®    
  • Loprox ®    
  • Imitrex ®    
  • Megace ®    
  • Buspar ®    
  • Wellbutrin SR ®    
  • Zyban ®, and many others
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.